Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

2.

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.

Lee JY, Chon GR, Rhee CK, Kim DK, Yoon HK, Lee JH, Yoo KH, Lee SH, Lee SY, Kim TE, Kim TH, Park YB, Hwang YI, Kim YS, Jung KS.

J Korean Med Sci. 2016 Apr;31(4):553-60. doi: 10.3346/jkms.2016.31.4.553. Epub 2016 Mar 10.

3.

Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.

Nagata K, Tomii K, Otsuka K, Tachikawa R, Otsuka K, Takeshita J, Tanaka K, Matsumoto T, Monden K.

Respirology. 2012 Apr;17(3):506-12. doi: 10.1111/j.1440-1843.2012.02131.x.

PMID:
22257381
4.

Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients.

Zhou QT, Mei JJ, He B, Huang SG, Shi Y, Wen FQ, Zhao MW.

Chin Med J (Engl). 2013 Jan;126(1):11-5.

PMID:
23286470
5.

Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.

Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YC, Lim SC.

BMC Pulm Med. 2013 Jun 3;13:35. doi: 10.1186/1471-2466-13-35.

6.

Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.

Lopez-Campos JL, Fernandez-Villar A, Calero-Acuña C, Represas-Represas C, Lopez-Ramírez C, Fernández VL, Soler-Cataluña JJ, Casamor R; On-Sint study group.

Int J Chron Obstruct Pulmon Dis. 2015 May 27;10:975-84. doi: 10.2147/COPD.S82781. eCollection 2015.

7.

[Relationship between degree of dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease].

Gvozdenović BS, Mitić S, Zugić VG, Gvozdenović AT, Lazović NM, Plavsić S.

Srp Arh Celok Lek. 2007 Sep-Oct;135(9-10):547-53. Serbian.

8.

Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.

Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS.

Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.

9.

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome.

Kurashima K, Takaku Y, Ohta C, Takayanagi N, Yanagisawa T, Sugita Y.

Int J Chron Obstruct Pulmon Dis. 2016 Mar 4;11:479-87. doi: 10.2147/COPD.S97343. eCollection 2016.

10.

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.

Jones PW, Adamek L, Nadeau G, Banik N.

Eur Respir J. 2013 Sep;42(3):647-54. doi: 10.1183/09031936.00125612. Epub 2012 Dec 20.

11.

Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Solanes-García I, Agüero R, Feu-Collado N, Calle-Rubio M, Alfageme I, de Diego-Damia A, Irigaray R, Marín M, Balcells E, Llunell A, Galdiz JB, Golpe R, Lacarcel C, Cabrera C, Marin A, Soriano JB, Lopez-Campos JL, Soler-Cataluña JJ, de-Torres JP; COPD History Assessment in Spain (CHAIN) Cohort.

Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.

PMID:
25612228
12.

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.

Rhee CK, Kim JW, Hwang YI, Lee JH, Jung KS, Lee MG, Yoo KH, Lee SH, Shin KC, Yoon HK.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.

13.

COPD assessment test (CAT): simple tool for evaluating quality of life of chemical warfare patients with chronic obstructive pulmonary disease.

Lari SM, Ghobadi H, Attaran D, Mahmoodpour A, Shadkam O, Rostami M.

Clin Respir J. 2014 Jan;8(1):116-23. doi: 10.1111/crj.12047. Epub 2013 Nov 5.

PMID:
23910892
14.

Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey.

Barnes N, Calverley PM, Kaplan A, Rabe KF.

BMC Pulm Med. 2013 Aug 23;13:54. doi: 10.1186/1471-2466-13-54.

15.

Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.

Huang WC, Wu MF, Chen HC, Hsu JY; TOLD Group.

NPJ Prim Care Respir Med. 2015 Nov 5;25:15063. doi: 10.1038/npjpcrm.2015.63.

16.

Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease.

Caillaud D, Chanez P, Escamilla R, Burgel PR, Court-Fortune I, Nesme-Meyer P, Deslee G, Perez T, Pinet C, Roche N; Initiatives BPCO Scientific Committee and Investigators.

Respirology. 2014 Apr;19(3):346-52. doi: 10.1111/resp.12224. Epub 2013 Dec 15.

17.

The overall impact of COPD (CAT) and BODE index on COPD male patients: correlation?

Ladeira I, Gomes T, Castro A, Ribeiro C, Guimarães M, Taveira N.

Rev Port Pneumol (2006). 2015 Jan-Feb;21(1):11-5. doi: 10.1016/j.rppnen.2014.02.004. Epub 2015 Jan 17.

PMID:
25854130
18.

[The evaluation of dyspnea and quality of life in COPD].

Demir G, Akkoca O, Doğan R, Saryal S, Karabiyikoğlu G.

Tuberk Toraks. 2003;51(4):365-72. Turkish.

PMID:
15143383
19.

Impact of adherence to GOLD guidelines on 6-minute walk distance, MRC dyspnea scale score, lung function decline, quality of life, and quality-adjusted life years in a Shanghai suburb.

Jiang YQ, Zhu YX, Chen XL, Xu X, Li F, Fu HJ, Shen CY, Lu YY, Zhuang QJ, Xu G, Cai YY, Zhang Y, Liu SS, Zhu MY, Li SH.

Genet Mol Res. 2015 Aug 3;14(3):8861-70. doi: 10.4238/2015.August.3.9.

20.

The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.

Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, Wang H, Liu YX, Wang DQ, Xu ZY, Wang HW, Zhang HS, He ZY, Yang T, Wang C.

Chin Med J (Engl). 2009 Dec 20;122(24):2939-44.

PMID:
20137478

Supplemental Content

Support Center